Glycosylated Peptide Market Size | COVID-19 Impact Analysis | Forecast to 2027
The global glycosylated peptide market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Peptide drugs are potential therapeutic agents. They are used to treat several diseases due to its features such as high activity, target specificity, low toxicity, and minimal non-specific or drug-drug interactions. Additionally, glycosylation of peptides is a strategy that modulates the physicochemical properties of peptide drugs. Further, it also penetrates peptides across biological membranes as well as enhances bioactivity, selectivity and prolong the half-life of the therapeutic drug. Moreover, there are two types of glycosylation of peptides including N-linked glycosylation or O-linked glycosylation.
The major factor driving the
demand for glycosylated peptide is the increasing application of glycosylated
peptides coupled with the increasing prevalence of chronic diseases such as
cancer, genetic disorders. Moreover, North America is expected to hold a
prominent share in the market due to the presence of major players in the
region.
To Request a Sample of our Report on Glycosylated
Peptide Market: https://www.omrglobal.com/request-sample/glycosylated-peptide-market
Some major players in the market include Pfizer Inc., Teva
Pharmaceutical Industries Ltd., Bachem Holding AG, among others. The market
players are contributing significantly to the growth of the market by the
adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in September 2021,
Pfizer Inc. and OPKO Health Inc. announced the extension of the review period
for the Biologics License Application (BLA) by three months to January 2022 for
somatrogon, a once-weekly long-acting recombinant human growth hormone, from
the US Food and Drug Administration (FDA). Somatrogon is an investigational
biologic product that is glycosylated and is used to treat growth hormone
deficiency (GHD) in pediatric patients.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
•
By Product
•
By Distribution Channel
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Pfizer Inc., Teva
Pharmaceutical Industries Ltd., and Bachem Holding AG, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Glycosylated Peptide Market is Available @ https://www.omrglobal.com/industry-reports/glycosylated-peptide-market
Global Glycosylated Peptide Market Report by Segment
By Product
•
Monoclonal Antibodies (mAbs)
•
Erythropoietin (EPO)
•
Others
By Distribution Channel
•
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
Global Glycosylated Peptide Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment